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Abstract Background: Mitochondrial diseases are a group
of disorders caused by mutations in nuclear DNA or
mitochondrial DNA, usually involving multiple organ
systems. Primary adrenal insufficiency due to mitochon-
drial disease is extremely infrequent and has been reported
in association with mitochondrial DNA deletion syndromes
such as Kearns–Sayre syndrome.
Aim: To report a 3-year-old boy with Addison disease,
congenital glaucoma, chronic pancreatitis, and mitochon-
drial myopathy due to large mitochondrial DNA deletion.
Method: Molecular analysis of mitochondrial DNA
samples obtained from peripheral blood, oral mucosa, and
muscle tissue.
Results: A novel large mitochondrial DNA deletion
of 7,372 bp was identified involving almost all genes on
the big arch of mtDNA.
Conclusions: This case reaffirms the association of
adrenal insufficiency and mitochondrial DNA deletions
and presents new evidence that glaucoma is another
manifestation of mitochondrial diseases. Due to the genetic
and clinical heterogeneity of mitochondrial disorders,
molecular analysis is crucial to confirm diagnosis and to
allow accurate genetic counseling.
Introduction
Primary adrenal insufficiency, commonly known as Addi-
son disease, is uncommon in the Western population and is
estimated to affect 90–140 per 1 million people (Arlt and
Allollo 2003). The spectrum of adrenal disorders differs in
childhood and adult patients. Primary adrenal insufficiency
in childhood and adolescence is due to abnormalities
of gland development, gland responsiveness, and either to
defects of steroid biosynthesis or target organ response.
Primary adrenal dysfunction associated with mitochon-
drial disease has been reported extremely infrequently
(Boles et al. 1998) and is generally associated with
mitochondrial DNA deletion syndromes such as Kearns–
Sayre Syndrome (KSS).
Clinical features typical of mitochondrial diseases
include ptosis, progressive external ophthalmoplegia
(PEO), proximal myopathy and exercise intolerance,
cardiomyopathy, sensorineural deafness, optic atrophy,
pigmentary retinopathy, and diabetes mellitus. KSS has
also been associated with a variety of endocrine disorders
such as short stature (38%), gonadal dysfunction (20%),
and diabetes mellitus (13%) (Harvey and Barnett 1992).
We report the case of a boy with Addison disease
associated with congenital glaucoma, chronic pancreatitis,




We present a 3-year-old male, who was the second child of
healthy and nonconsanguineous white parents, born after
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uneventful pregnancy and delivery. He was a 3.2 kg and
49 cm term newborn without a family history of hereditary
diseases, and who showed normal growth and development.
At 2 years of age, he was admitted to the hospital for
abdominal pain, vomiting, and lethargy of unknown
etiology; during that episode, he also had hyponatremia,
elevated blood lactate of 6.6 mmol (normal < 2.2 mmol),
and normal abdominal ultrasound.
Three months later, he presented with acute bilateral
photophobia. The ophthalmologic examination revealed
megalocornea and increased intraocular pressure. Congeni-
tal glaucoma was diagnosed and the patient underwent
trabeculectomy.
At the age of 210/12 years, endocrinological examination
showed relative short stature (1.7 SD), increased pigmen-
tation of skin and mucosa, and normal development of
genitals for age without pubarche. These findings and the
history of hyponatremia suggested adrenal insufficiency,
which was confirmed by normal cortisol (7.6 mg/dL) but
markedly elevated serum ACTH (911 pg/mL) levels. After
the intravenous administration of 250 mg ACTH, the cortisol
level was 7.9 mg/dL, 17OH-progesterone was 0.6 ng/dL, and
testosterone was < 10 ng/dL. Initially, plasma renin activity
(PRA) was in the normal range. Very long chain fatty acid
and phytanic acid were normal, antibodies to the adrenal
cortex were not detected and brain MRI was normal.
Hydrocortisone replacement therapy was introduced
(10 mg/m2/day) leading to normalization of ACTH and
skin pigmentation. During follow-up, PRA increased to
12 ng/ml/h (normal 1.6–5.0 ng/ml/h), so Florinef ™ was
added at a dose of 0.1 mg/day.
Abdominal ultrasound showed a calcified pancreas and
parenchymal changes consistent with chronic pancreatitis,
although the patient had no history of recurrent abdominal
pain, anorexia, diarrhea, or cyclic vomiting, nor was there
any history of abdominal trauma or family pancreatic
disease. The abdomen was soft, and there was no
hepatosplenomegaly. Liver function, amylase, lipase, and
blood cell count were normal; antinuclear and anti-DNA
antibodies were negative. Extensive absorption work-up
was negative. The magnetic resonance cholangiopancrea-
tography (MRCP) revealed diffuse pancreatic calcification
and decreased pancreatic size with abnormal limits and
fatty infiltration. In addition, the main pancreatic duct was
diffusely dilated with multiple ductal filling defects,
probably due to intraductal pancreatic stones. Based on
this evidence, the patient was diagnosed with chronic
pancreatitis, and he was started with pancreatic enzyme
supplementation (Creon®).
The multisystem involvement, characterized by congeni-
tal glaucoma, chronic pancreatitis, and Addison disease,
suggested a mitochondrial disease. Echocardiogram, elec-
trocardiogram, and neurologic examination were normal,
but muscle biopsy showed typical ragged-red fibers,
confirming the diagnosis of mitochondrial disease.
Molecular Studies
DNA was extracted from peripheral blood lymphocytes,
oral mucosa cells, and muscle tissue by a commercial
method (QIAgen). Mitochondrial DNA deletion analysis
was performed by amplifying the entire mitochondrial
genome (16,569 bp) in a single reaction, as well as seven
smaller fragments in separate reactions, thus encompassing
the big arc of the mitochondrial genome. For whole-
genome analysis, the D1A and D1B primers were used
(Kleinle et al. 1997). For the smaller fragments, we used the
following primers: mtF5317 (5317–5333), mtF7392
(7392–7410), mtF8196 (8196–8215), mtF11632
(11632–11651), mtR13832 (13832–13812), mtR15613
(15613–15594), and mtR16134 (16134–16115), as
described by Ferlin et al. (1997). The primers were used
according to the following combinations: mtF5317/
mtR13832 (fragment 1), mtF5317/mtR16134 (fragment 2),
mtF7392/mtR15613 (fragment 3), mtF8196/mtR13832
(fragment 4), mtF8196/mtR16134 (fragment 5), mtF8196/
mtR15613 (fragment 6), and mtF11632/mtR16134 (frag-
ment 7). All fragments were amplified by long PCR under
the same conditions, using a long PCR enzyme mix
(Fermentas Life Sciences) in a final volume of 25 mL, and
the cycling program used by Kleinle et al. (1997). Five ml
of the products were separated on a 0.8% agarose gel and
visualized under UV. The deletion breakpoints were studied
by sequencing the fragments encompassing the deletion
using the amplification primers.
Results
Molecular Studies
Long PCR analysis of the whole mitochondrial genome and
of mtDNA segments with the first and second primer pairs
showed shorter amplification fragments than those obtained
with the wild-type sample. The deletion in peripheral blood,
oral mucosa, and muscle had a size of ~7 kb as estimated
by gel analysis (Fig. 1). After sequencing fragment 1, the
exact deletion size was determined to encompass 7,372 bp,
including 16 genes and flanked by direct repeats. Deletion
size, breakpoints, the repeat sequence, and the genes
abrogated by the deletion are shown in Fig. 2.
Discussion
Mitochondrial disorders are often considered rare condi-
tions seen only in children with severe neurological
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impairment and multisystem failure. Here, we describe a
3-year-old boy with Addison disease, congenital glaucoma,
chronic pancreatitis, and mitochondrial myopathy, but
without central nervous system involvement who harbored
a single large mtDNA deletion.
Mitochondrial DNA deletion syndromes included three
phenotypes: KSS (OMIM, # 530000), Pearson syndrome
(OMIM, # 557000), and PEO. KSS is characterized by the
triad of onset before age 20, PEO, pigmentary retinopathy,
and at least one of the following features: heart block,
ataxia, and cerebrospinal fluid (CSF) protein > 100 mg/dl.
Frequent additional signs include short stature, micro-
cephaly, sensorineural hearing loss, cardiomyopathy, renal
tubular acidosis and Fanconi syndrome, muscle weakness,
basal ganglia calcifications, diffuse signal abnormality of
central white matter, dementia, and sensory or motor
neuropathy.
Pearson syndrome is characterized by refractory side-
roblastic anemia and vacuolization of marrow precursors, as
well as exocrine pancreatic dysfunction with malabsorption
and pancreatic fibrosis.
Abnormalities of the adrenal axis have been found in patients
with KSS. Boles et al. (1998) published a case with mtDNA
deletion and Addison disease as a prominent clinical feature.
Sanaker et al. (2007) reported a young woman who developed
Addison disease, hypothyroidism, and glucose intolerance
associated with thyroid peroxidase antibodies and adrenal 21-
hydroxylase antibodies. Other endocrinopathies such as early-
onset diabetes mellitus (R€otig et al. 1993), growth hormone
deficiency (G€uc€uyener et al. 1998), and hypoparathyroidism
(Cassandrini et al. 2006) have also been report in patients with
single mtDNA deletions.
Congenital glaucoma was described in a child with KSS
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Fig. 1 (a): PCR products after whole mitochondrial genome amplifi-
cation. Lane 1: molecular weight standard (23.1, 9.4, 6.6, 4.4, 2.3, 2.0,
0.5 kb), Lane 2: negative control, Lane 3: wild-type sample with a
major fragment (16 kb), Lane 4: patient sample with a smaller
fragment (9 kb). (b) PCR products after amplification of fragments 1
(lanes 2–5) and 2 (lanes 7–10). Lane 1 and 6: molecular weight
standard (10, 8, 6, 5, 4, 3.5, 3, 2.5, 2, 1.5, 1, 0.75, 0.5, 0.25 kb), Lanes
2, 5, 7 and 10: wild-type sample. Lanes 3, 4, 8 and 9: patient samples
(blood and mucosal cells, respectively). All other amplicons (frag-
ments 3, 4, 5, 6 and 7) from the patient had normal-sized bands
ND1 ND2 COI COII ATPase8ATP ase6 COIII ND3 ND4L ND4 ND5 ND6 Cyt b
7372 bp
a




13706                   ND5
b
Fig. 2 (a): schematic of the deletion size and genes involved. (b): Nucleotide sequence and mitochondrial DNA position flanking the repeat
region (repeat sequence in bold)
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coincidence (Simaan et al. 1999). Normally, the ciliary
muscles supplies some force to the trabecular meshwork,
increasing the absorption of the aqueous humor. Thus,
a decrease in outflow might be secondary to the ciliary
mitochondrial myopathy, leading to reduction in aqueous
humor absorption, increased ocular pressure, and glaucoma.
Acute or chronic pancreatitis associated with mitochon-
drial diseases is rare in childhood (Kishnani et al. 1996a).
The incidence of pancreatic calcification varies from 19.9%
to 83.1% in adults with chronic pancreatitis (Stobbe et al.
1970) and the relationship between calcification and
exocrine pancreatic function is not linear. Pancreatic
calcifications are virtually pathognomonic of chronic
pancreatitis and develop in up to 90% of adult patients
with alcoholic chronic pancreatitis (Ammann et al. 1988),
but no information is available for younger patients. We
could not document pancreatic insufficiency in this patient,
but it is likely that the calcifications characterize more
severe forms of chronic pancreatitis even in the early
phases of the disease (Scuro et al. 1990).
Pancreatic dysfunction has been described in Pearson’s
disease associated with diabetes mellitus. There have been
only a few reports of mitochondrial myopathy associated
with pancreatitis (Kato et al. 1990; Toyono et al. 2001). Tsao
et al. (2000) reported an infant with chemical pancreatitis
due to mtDNA depletion. In addition, pancreatitis and
pancreatic calcifications have been reported in patients with
the m.3243A > G mutation in mitochondrial DNA, the
“MELAS mutation” (Kishnani et al. 1996b; Schleiffer et al.
2000). In our patient, the abdominal ultrasound and MRCP
suggested the diagnosis of chronic pancreatitis, although he
was asymptomatic and had no steatorrhea. Fintesterer (2000)
recommends that, when a mitochondrial disease is suspected,
the history should always include queries on the presence or
absence of pancreatitis (Finsterer 2007).
In this case, the clinical suspicion of a mitochondrial
deletion was very strong. Using this methodological
approach, we were able to describe a novel large mitochon-
drial DNA deletion involving almost all genes on the big arc,
flanked by short direct repeats, as often described for mtDNA
deletions (Kleinle et al. 1997; Yamashita et al. 2008). We
demonstrated this large deletion of mitochondrial DNA in
at least three different tissues of this patient. Given the
clinical manifestations, we may assume that it is present in
other cell types, but we could not prove it, as well as the
heteroplasmic mutation level. The patient reported by Boles
et al. (1998), who also presented with Addison disease, had
a smaller deletion. On the other hand, there are cases with
similar deletion sizes but without Addison disease, rein-
forcing the concept that genotype does not always or
exactly correlate with phenotype (Yamashita et al. 2008).
Due to the genetic and clinical heterogeneity of mitochon-
drial disorders, it is especially important to have access to
molecular analysis to confirm diagnoses and to achieve
more precise genetic counseling (Wong 2007).
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